The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999-2010
Abstract
BACKGROUND: Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are common infections with serious sequelae. HSV-1 is an increasingly important cause of genital herpes in industrialized countries. METHODS: Using nationally representative data from the National Health and Nutrition Examination Survey (NHANES), we examined HSV-1 and HSV-2 seroprevalence among 14- to 49-year-olds in the United States. We estimated seroprevalence in 1999-2004 and 2005-2010, stratified by sociodemographic characteristics and sexual behaviors. We also reviewed HSV-1 and HSV-2 seroprevalence from 1976-1980 to 2005-2010. RESULTS: In 2005-2010, the seroprevalence of HSV-1 was 53.9%, and the seroprevalence of HSV-2 was 15.7%. From 1999-2004 to 2005-2010, HSV-1 seroprevalence declined by nearly 7% (P < .01), but HSV-2 seroprevalence did not change significantly. The largest decline in HSV-1 seroprevalence from 1999-2004 to 2005-2010 was observed among adolescents aged 14-19 years, among whom seroprevalence declined by nearly 23%, from 39.0% to 30.1% (P < .01). In this age group, HSV-1 seroprevalence declined >29% from 1976-1980 to 2005-2010 (P < .01). CONCLUSIONS: An increasing number of adolescents lack HSV-1 antibodies at sexual debut. In the absence of declines in HSV-2 infections, the prevalence of genital herpes may increase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Self-citationTrends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E. (2006) · JAMA · doi:10.1001/jama.296.8.964 · Cited by 1,035
Self-citationGlycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Design and estimation for the National Health Interview Survey, 1995-2004
Botman, S., & Moriarity, C. L. (2000) · Cited by 785
Ashley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Belshe, R. B., Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. A., Ewell, M. G., Stokes-Riner, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103151 · Cited by 510
A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510
Abma, J. C., Martinez, G. M., & Copen, C. E. (2010) · PubMed · Cited by 493
Epidemiologic studies utilizing surveys: accounting for the sampling design.
Korn, E. L., & Graubard, B. I. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.9.1166 · Cited by 490
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140765 · Cited by 644
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management
Bradshaw, M. J., & Venkatesan, A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0433-7 · Cited by 492
Tzeng, N.-S., Chung, C.-H., Lin, F.-H., Chiang, C.-P., Yeh, C.-B., Huang, S.-Y., Lu, R.-B., Chang, H.-A., Kao, Y.-C., Yeh, H.-W., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0611-x · Cited by 356
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
“9% (234) of the non-paediatric population of the United States, respectively, with detection of viral RNA (indicating active replication) in cases of sepsis occurring in 24.”
BackgroundThe growing epidemic of sexually transmitted infections in adolescents: a neglected population
Shannon, C. L., & Klausner, J. D. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000578 · Cited by 298
Time to test antibacterial therapy in Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Watling, M., & Imbimbo, B. P. (2019) · Brain · doi:10.1093/brain/awz244 · Cited by 161
Incomplete penetrance in primary immunodeficiency: a skeleton in the closet
Gruber, C., & Bogunovic, D. (2020) · Human Genetics · doi:10.1007/s00439-020-02131-9 · Cited by 97
Tenofovir gel for the prevention of herpes simplex virus Type 2 infection.
Abdool Karim, S. S., Abdool Karim, Q., Kharsany, A. B. M., Baxter, C., Grobler, A. C., Werner, L., Kashuba, A., Mansoor, L. E., Samsunder, N., Mindel, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410649 · Cited by 92
The Role of Antiviral Therapy in Immunocompromised Patients With Herpes Simplex Virus Meningitis
Noska, A., Kyrillos, R., Hansen, G., Hirigoyen, D., & Williams, D. N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu772 · Cited by 45
Replicated methylation changes associated with eczema herpeticum and allergic response
Boorgula, M. P., Taub, M. A., Rafaels, N., Daya, M., Campbell, M., Chavan, S., Shetty, A., Cheadle, C., Barkataki, S., Fan, J., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0714-1 · Cited by 28
Metadata
- Authors
- Bradley, H., Markowitz, L. E., Gibson, T., & McQuillan, G. M.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-16
- Volume
- 209
- Issue
- 3
- Pages
- 325-333
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2059790365
- Cited by
- 432
- References
- 24
- FWCI
- 25.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.